Currently submitted to: JMIR Public Health and Surveillance
Date Submitted: Nov 10, 2026
Open Peer Review Period: Nov 16, 2026 - Jan 11, 2027
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Dynamic Trends and Early-Warning Signals of Infectious Disease Screening Positivity at Border Ports in Yunnan Province: A Time-Series Study Using Monthly Sentinel Surveillance Data
ABSTRACT
Background:
Border ports are important sentinel sites for detecting changes in infectious disease risks associated with population mobility. We characterized monthly trends and statistical early-warning signals for hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and syphilis screening positivity at two border ports in Yunnan Province, China.
Objective:
This study aimed to characterize monthly trends in screening positivity for hepatitis B virus, hepatitis C virus, HIV, and syphilis at the Hekou and Mengla border ports in Yunnan Province, China, and to identify statistical early-warning signals using routinely collected sentinel surveillance data.
Methods:
We conducted a retrospective time-series study using monthly screening data from Hekou and Mengla ports between January 2023 and December 2025. The dataset comprised 78,301 screening examinations across 72 port-months, with monthly outcomes available for overall positivity and four pathogen-specific markers. Pathogen-specific temporal patterns were evaluated using binomial generalized additive models and linear trend models. Data from 2023–2024 were prespecified as the historical reference period, and observations from 2025 were monitored using one-sided exponentially weighted moving average (EWMA) and cumulative sum (CUSUM) charts. Concordant signals and synchronous multi-pathogen alerts were also assessed.
Results:
HBV was the predominant positive marker, with pooled positivity of 7.34% at Hekou and 10.58% at Mengla. HBV positivity declined significantly at Mengla (odds ratio [OR] per 12 months, 0.87; 95% confidence interval [CI], 0.83–0.91) but not at Hekou. HCV positivity declined at Hekou (OR, 0.77; 95% CI, 0.64–0.93), whereas no significant trend was observed at Mengla. HIV positivity showed no significant long-term trend at either port. Syphilis positivity increased at both Hekou (OR, 1.33; 95% CI, 1.16–1.52) and Mengla (OR, 1.28; 95% CI, 1.14–1.45). In 2025, Hekou syphilis generated EWMA signals in all 12 months and concordant EWMA–CUSUM signals from March through December. At Mengla, HCV was flagged by at least one method in five months, HIV generated an isolated EWMA signal in January, and syphilis produced concordant signals from October through December. Synchronous HCV–syphilis alerts occurred at Mengla in October and November. Trend-adjusted sensitivity analyses substantially attenuated the syphilis warnings at both ports, whereas HCV warnings at Mengla remained evident after adjustment for the expected temporal trajectory.
Conclusions:
Monthly port surveillance identified pathogen- and location-specific changes that were obscured by aggregate positivity. Persistent fixed-baseline syphilis elevations and HCV anomalies that remained after trend adjustment warrant targeted verification. EWMA and CUSUM charts may complement conventional trend analyses, although their signals should prompt epidemiological investigation rather than be interpreted as evidence of outbreaks.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.